Evaluation of clinical performance of two calcium silicate-based materials for pulpotomy: A randomized clinical trial.
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- More than 75% of patients receiving pulpotomy by the materials used in the study will be preserving the pulp vitality
研究概览
简要总结
The optimal prognosis of vital pulp therapy is based on the elimination of etiologic factors with complete removal of diseased and contaminated tissues as well as the appropriate restoration of the tooth. Therefore, vital pulp therapy is preferred to reduce the risk of infection and further damage to the pulp with a material that should be biocompatible, provide a biological seal, and prevent bacterial leakage. Currently calcium silicate-based materials are considered for vital pulp therapies like pulp capping and pulpotomy procedures. Several studies have shown successful results using Biodentine and MTA as pulpotomy agents but, there are very few clinical studies till date comparing the calcium silicate materials used for pulpotomy in permanent teeth.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •patients who are asymptomatic/symptomatic reversible pulpitis with deep dental caries in posterior teeth close to pulp chamber and bleeding easily controlled after pulp exposure and site of exposure is large.
排除标准
- •very small pulp exposure or any h/o of spontaneous pain, periapical lesion and bleeding not controlled after pulp exposure.
结局指标
主要结局
More than 75% of patients receiving pulpotomy by the materials used in the study will be preserving the pulp vitality
时间窗: 1 year
次要结局
- In more the 75% patients the signs & symptoms of pulpitis such as tooth ache will be cured(1 YEAR)
研究者
Yellapu Shenkari Indumathi
DRS. SUDHA & NAGESWARA RAO SIDDHARTHA INSTITUTE OF DENTAL SCIENCES